Taro Pharmaceutical Industries Ltd (NYSE:TARO)

116.82
Delayed Data
As of 12:10pm ET
 -0.68 / -0.58%
Today’s Change
93.01
Today|||52-Week Range
128.46
+11.57%
Year-to-Date

Today’s Trading

Previous close117.50
Today’s open116.74
Day’s range115.91 - 117.67
Volume15,925
Average volume (3 months)74,983
Market cap$4.5B
Data as of 12:10pm ET, 06/25/2018

Growth & Valuation

Earnings growth (last year)-12.51%
Earnings growth (this year)-52.26%
Earnings growth (next 5 years)+15.00%
Revenue growth (last year)-7.51%
P/E ratio22.2
Price/Sales5.48
Price/Book2.19

Competitors

 Today’s
change
Today’s
% change
ACADACADIA Pharmaceutica...-0.41-2.51%
AKRXAkorn Inc-0.38-2.37%
----
MNKMallinckrodt Plc+0.04+0.21%
Data as of 12:33pm ET, 06/25/2018

Financials

Next reporting dateAugust 8, 2018
EPS forecast (this quarter)$1.98
Annual revenue (last year)$879.4M
Annual profit (last year)$456.4M
Net profit margin51.93%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Uday Vijaykumar Baldota
Vice President &
Operations Head-Haifa
Itamar Karsenti
Corporate headquarters
Haifa Bay, Haifa

Forecasts